BR112014029409A2 - - Google Patents
Info
- Publication number
- BR112014029409A2 BR112014029409A2 BR112014029409A BR112014029409A BR112014029409A2 BR 112014029409 A2 BR112014029409 A2 BR 112014029409A2 BR 112014029409 A BR112014029409 A BR 112014029409A BR 112014029409 A BR112014029409 A BR 112014029409A BR 112014029409 A2 BR112014029409 A2 BR 112014029409A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261651642P | 2012-05-25 | 2012-05-25 | |
US61/651,642 | 2012-05-25 | ||
US201361776918P | 2013-03-12 | 2013-03-12 | |
US61/776,918 | 2013-03-12 | ||
PCT/US2013/042429 WO2013177398A2 (en) | 2012-05-25 | 2013-05-23 | Non-natural consensus albumin binding domains |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014029409A2 true BR112014029409A2 (pt) | 2017-08-15 |
BR112014029409B1 BR112014029409B1 (pt) | 2022-11-29 |
Family
ID=49622071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014029409-7A BR112014029409B1 (pt) | 2012-05-25 | 2013-05-23 | Domínio de ligação a albumina isolado não natural, método para produção do mesmo, polinucleotídeo isolado, vetor isolado, célula hospedeira isolada, proteína de fusão e composição farmacêutica |
Country Status (16)
Country | Link |
---|---|
US (3) | US9156887B2 (pt) |
EP (1) | EP2855509B1 (pt) |
JP (3) | JP2015519345A (pt) |
KR (1) | KR102053674B1 (pt) |
CN (1) | CN104470944B (pt) |
AU (2) | AU2013266215B2 (pt) |
BR (1) | BR112014029409B1 (pt) |
CA (1) | CA2874646C (pt) |
DK (1) | DK2855509T3 (pt) |
EA (1) | EA036487B1 (pt) |
ES (1) | ES2670442T3 (pt) |
HK (1) | HK1209134A1 (pt) |
IL (2) | IL235808A (pt) |
MX (1) | MX355041B (pt) |
PT (1) | PT2855509T (pt) |
WO (1) | WO2013177398A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9695228B2 (en) | 2012-11-21 | 2017-07-04 | Janssen Biotech, Inc. | EGFR and c-Met fibronectin type III domain binding molecules |
US10093921B2 (en) * | 2013-03-14 | 2018-10-09 | The Governing Council Of The University Of Toronto | Scaffolded peptidic libraries and methods of making and screening the same |
HUE046343T2 (hu) * | 2015-04-29 | 2020-02-28 | Mediolanum Farm S P A | Oldható, kiméra interleukin-10 receptor és terápiás alkalmazása |
WO2016204884A1 (en) * | 2015-06-18 | 2016-12-22 | Albert Einstein College Of Medicine, Inc. | Fgf receptor ligands for treating diabetes and obesity |
CN106699842B (zh) * | 2015-11-17 | 2020-06-12 | 上海交通大学 | 一种新的抗炎小分子多肽及其应用 |
CA3054286A1 (en) | 2016-03-01 | 2017-09-08 | The Board Of Trustees Of The University Of Illinois | L-asparaginase variants and fusion proteins with reduced l-glutaminase activity and enhanced stability |
US10611823B2 (en) | 2016-12-14 | 2020-04-07 | Hanssen Biotech, Inc | CD137 binding fibronectin type III domains |
JP7104703B2 (ja) | 2016-12-14 | 2022-07-21 | ヤンセン バイオテツク,インコーポレーテツド | Cd8a結合フィブロネクチンiii型ドメイン |
US10443049B2 (en) | 2017-01-24 | 2019-10-15 | Northwestern University | Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2) |
US11578315B2 (en) | 2017-08-11 | 2023-02-14 | The Board Of Trustees Of The University Of Illinois | Truncated guinea pig L-asparaginase variants and methods of use |
WO2019175176A1 (en) | 2018-03-13 | 2019-09-19 | Affibody Ab | Polypeptides based on a novel scaffold |
KR102282240B1 (ko) * | 2018-12-06 | 2021-07-28 | 경상국립대학교산학협력단 | 지속형 엑센딘-4 및 이의 용도 |
US11781138B2 (en) | 2019-10-14 | 2023-10-10 | Aro Biotherapeutics Company | FN3 domain-siRNA conjugates and uses thereof |
WO2021076546A1 (en) | 2019-10-14 | 2021-04-22 | Aro Biotherapeutics Company | Cd71 binding fibronectin type iii domains |
CA3161723A1 (en) * | 2019-12-18 | 2021-06-24 | Karyn O'neil | Serum albumin-binding fibronectin type iii domains and uses thereof |
CA3214552A1 (en) | 2021-04-14 | 2022-10-20 | Russell C. Addis | Cd71 binding fibronectin type iii domains |
CN113336860B (zh) * | 2021-06-02 | 2022-07-01 | 北京大学 | 一种具有靶向和长效功能的重组水蛭素融合蛋白及其编码基因和应用 |
WO2024102190A2 (en) * | 2022-11-09 | 2024-05-16 | Avitide LLC | Affinity agents |
WO2024130179A1 (en) | 2022-12-16 | 2024-06-20 | Repertoire Immune Medicines, Inc. | T cell receptors binding hpv-16 epitopes |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267964B1 (en) | 1989-08-01 | 2001-07-31 | Affibody Technology Sweden Ab | Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives |
EP0640135B1 (en) * | 1992-05-07 | 2001-01-17 | Affitech As | Immunoglobulin binding proteins derived from l protein and their uses |
WO1994012520A1 (en) | 1992-11-20 | 1994-06-09 | Enzon, Inc. | Linker for linked fusion polypeptides |
US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
PT1015576E (pt) | 1997-09-16 | 2005-09-30 | Egea Biosciences Llc | Metodo para a sintese quimica completa e montagem de genes e de genomas |
US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
WO2001045746A2 (en) | 1999-12-24 | 2001-06-28 | Genentech, Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
CN104710518A (zh) | 2007-07-31 | 2015-06-17 | 阿菲博迪公司 | 新白蛋白结合组合物、方法及应用 |
KR20110039220A (ko) | 2008-06-30 | 2011-04-15 | 교와 핫꼬 기린 가부시키가이샤 | 항cd27 항체 |
DK2356269T3 (en) * | 2008-10-31 | 2016-08-15 | Janssen Biotech Inc | FIBRONECTIN TYPE III DOMAIN-BASED SCAFFOLD COMPOSITIONS, PROCEDURES AND APPLICATIONS |
JP5557254B2 (ja) * | 2009-02-10 | 2014-07-23 | 国立大学法人 琉球大学 | 薬物運搬体並びにこれを利用したアジュバントおよびワクチン |
WO2010093627A2 (en) | 2009-02-12 | 2010-08-19 | Centocor Ortho Biotech Inc. | Fibronectin type iii domain based scaffold compositions, methods and uses |
WO2010141329A1 (en) * | 2009-06-01 | 2010-12-09 | Medimmune, Llc | Molecules with extended half-lives and uses thereof |
EA201690310A1 (ru) | 2010-04-13 | 2016-12-30 | Селлдекс Терапьютикс Инк. | Антитела, связывающие cd27 человека, и их применение |
RU2603272C2 (ru) * | 2010-04-30 | 2016-11-27 | Янссен Байотек, Инк. | Композиции на основе стабилизированных фибронектиновых доменов, способы и области их применения |
US9695228B2 (en) * | 2012-11-21 | 2017-07-04 | Janssen Biotech, Inc. | EGFR and c-Met fibronectin type III domain binding molecules |
-
2013
- 2013-05-23 KR KR1020147035989A patent/KR102053674B1/ko active IP Right Grant
- 2013-05-23 ES ES13793564.9T patent/ES2670442T3/es active Active
- 2013-05-23 EP EP13793564.9A patent/EP2855509B1/en active Active
- 2013-05-23 WO PCT/US2013/042429 patent/WO2013177398A2/en active Application Filing
- 2013-05-23 MX MX2014014384A patent/MX355041B/es active IP Right Grant
- 2013-05-23 PT PT137935649T patent/PT2855509T/pt unknown
- 2013-05-23 US US13/901,013 patent/US9156887B2/en active Active
- 2013-05-23 CN CN201380039335.8A patent/CN104470944B/zh active Active
- 2013-05-23 AU AU2013266215A patent/AU2013266215B2/en active Active
- 2013-05-23 EA EA201590136A patent/EA036487B1/ru unknown
- 2013-05-23 DK DK13793564.9T patent/DK2855509T3/en active
- 2013-05-23 CA CA2874646A patent/CA2874646C/en active Active
- 2013-05-23 JP JP2015514183A patent/JP2015519345A/ja not_active Withdrawn
- 2013-05-23 BR BR112014029409-7A patent/BR112014029409B1/pt active IP Right Grant
-
2014
- 2014-11-20 IL IL235808A patent/IL235808A/en active IP Right Grant
-
2015
- 2015-09-01 US US14/842,218 patent/US20160083436A1/en not_active Abandoned
- 2015-10-06 HK HK15109729.2A patent/HK1209134A1/xx unknown
-
2017
- 2017-09-20 US US15/710,385 patent/US10280200B2/en active Active
- 2017-09-24 IL IL254652A patent/IL254652B/en active IP Right Grant
- 2017-11-17 AU AU2017261625A patent/AU2017261625B2/en active Active
-
2018
- 2018-06-18 JP JP2018115294A patent/JP7166081B2/ja active Active
-
2020
- 2020-09-23 JP JP2020158256A patent/JP2021019595A/ja active Pending
Also Published As
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/05/2013, OBSERVADAS AS CONDICOES LEGAIS |